NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Dwayne Dunaway

Amber Ratcliffe

NanoString Technologies, Inc.

Spekle Solutions specializes in shaping market access and commercial strategies for life sciences. The company uses advanced analytical techniques and technology to provide customized solutions and insights.

Spekle Solutions

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications.NanoString's products are based on a novel digital molecular barcoding technology invented at the Institute for Systems Biology (ISB) in Seattle under direction of Dr. Leroy Hood. The company was founded in 2003 with an exclusive license to develop and market the technology. In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis. In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection. In 2019, the company launched the GeoMx™ Digital Spatial Profiler enabling highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. In 2022, the company launched CosMxTM Spatial Molecular Imager, enabling the first high-plex in situ analysis platform to provide spatial multi-omics with formalin-fixed paraffin-embedded (FFPE) and fresh frozen (FF) tissue samples at cellular and subcellular resolution. CosMx SMI is a flexible, spatial single-cell imaging platform that will drive deeper insights for cell atlasing, tissue phenotyping, cell-cell interactions, cellular processes, and biomarker discovery. In 2022, AtoMx™ Spatial Informatics Platform (SIP), the only cloud-based, fully-integrated informatics platform for spatial biology, was also launched.

Metric
Company Name	NanoString Technologies, Inc.	Spekle Solutions
Symbol	NSTG
MSH ID	COM:NANOSTRING	COM:SPEKLESOLUTIONS
Market	STOCKS	PRIVATE
Sector	Healthcare	Commercial & Professional Services
Industry	Medical - Instruments & Supplies	Consulting
Country	US	US
Stage
Employee Count	550
Website	nanostring.com	speklesolutions.com
LinkedIn	nanostring-technologies
Founders

Metric
Market Cap	5.07M
Enterprise Value
Monthly Web Traffic	22.02K
Web Traffic Growth	-0.58
Valuation
Raised Capital	47.50M

Metric
Revenue	127.26M
Revenue (LTM)
Revenue (NTM)
Gross Profit	61.79M
EBITDA	-151.69M
Operating Income	-152.18M
Net Income	-159.54M
EPS	-3.44
Diluted EPS	-3.44
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.36
Operating Profit Margin	-0.94
EBITDA Margin	-1.19
Net Profit Margin	-0.96
Return on Equity	52.86
Return on Assets	-0.45
Return on Capital Employed	-0.61

COM:NANOSTRING

NanoString Technologies, Inc.

Last Close

0.17

14/11 21:00

Market Cap

5.07M

Beta: -

Volume Today

21.43M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-0.03
P/B Ratio	-0.10
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.04
EV Multiple	1.32

Metric
Days Sales Outstanding	108.62
Days Payables Outstanding	116.50
Days Inventory Outstanding	241.65
Operating Cycle	379.48
Cash Conversion Cycle	233.44
Asset Turnover	0.59

Metric
Operating Cash Flow	-128.61M
Free Cash Flow	-151.67M
Cash Flow to Debt	-0.35
Operating Cash Flow/Sales	-0.68
Free Cash Flow Yield	-26.49

Metric
Cash & Equivalents	112.25M
Accounts Receivable	7.41M
Inventory	43.27M
Goodwill
Debt to Capitalization	1.26
Debt to Assets	0.90
Current Ratio	2.73
Quick Ratio	2.02

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.18
R&D to Revenue	0.43
SG&A to Revenue